ABP Pediatric Hematology-Oncology Practice Questions - ABP Pediatric Hematology-Oncology Subspecialty Certification Examination Exam

Access More Questions

A 4-year-old with newly diagnosed B-ALL has blasts positive for BCR-ABL1 (Philadelphia chromosome, t(9;22)). What targeted agent should be added to chemotherapy?

Venetoclax Rituximab Brentuximab vedotin Dasatinib (tyrosine kinase inhibitor)

Correct Answer:

Dasatinib (tyrosine kinase inhibitor)

Access more questions from this quiz

Continue to ABP Pediatric Hematology-Oncology Practice Questions - ABP Pediatric Hematology-Oncology Subspecialty Certification Examination Exam for more practice questions and the full quiz experience.

Access More Questions